Shares of Agilent Technologies Inc. A rose 1.10% to $108.70 Thursday, on what proved to be an all-around favorable trading ...

Agilent Technologies recently introduced the Seahorse XF Flex Analyzer, enhancing its position in metabolic analysis for complex 3D models. Despite this product launch, the company's stock showed ...

The NEW 5977B High Efficiency Source (HES) GC/MSD builds on a tradition of providing the most trusted single-quadrupole GC/MS system. The ultra-efficient EI source maximizes the number of ions ...

BDT & MSD Partners alum Adam Piekarski is starting anew and has formed Derby Lane Partners, a new real estate credit investment firm, according to a person with knowledge of the matter.

The Agilent 490 Micro GC is a rugged, compact, laboratory quality gas chromatograph that delivers information you need, wherever you need it. The fifth generation 490 Micro GC is designed to ...

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences ...

West Monroe was founded in 2002. Correction: An earlier version of this news item misstated that West Monroe is backed by MSD Capital. That is incorrect and has since been rectified.

“Whatever decision MSD made about playing this season would have been based solely on what’s best for CSK.” Dhoni was retained by CSK for INR 4 crore, after a rule change that dictated ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage non ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

A subcutaneous formulation of MSD's top-selling cancer immunotherapy, Keytruda, was non-inferior to the current intravenous version in a head-to-head trial, setting up regulatory filings.